MORRISVILLE, N.C. and NEW YORK, March 26, 2026 /PRNewswire/ — Peritia, a prominent consulting firm in the biopharmaceutical and medtech sectors, has announced the appointment of Michael Griffith as Chief Executive Officer. With over 25 years of experience in executive leadership, Mr. Griffith is poised to enhance the company’s growth trajectory.
A Platform Builder with Proven Impact
Prior to joining Peritia, Mr. Griffith was the founder and CEO of Amplity Health, a global contract medical and commercial organisation that operates in 40 countries and employs more than 1,000 professionals. His tenure at Amplity has provided him with extensive experience in building and scaling pharmaceutical services businesses.
Before Amplity, he served as Operating Partner at Altamont Capital Partners, where he focused on investments in biopharmaceutical outsourcing companies. Additionally, Mr. Griffith held the position of President of the Commercial Division at inVentiv Health, a leading provider of biopharmaceutical outsourcing services. His career also includes roles as CEO at ChiRex, Aptuit, and Laureate Biopharma, all recognised leaders in contract drug development and manufacturing. Mr. Griffith has also contributed his expertise as a board member for Repligen Corporation and several other public life sciences companies. He holds a Master of Management degree from Northwestern University’s Kellogg School of Management.
Strategic Vision for Peritia
In Mr. Griffith’s view, the current landscape of biopharma and medtech funding presents a unique opportunity for Peritia. “Peritia is exactly the kind of platform the industry needs right now — one that combines scientific depth, strategic advisory, and operational capability to our client engagements,” he remarked. Over the past five years, Peritia has successfully completed more than 1,100 engagements across 20 countries for 355 clients. Mr. Griffith emphasised the company’s commitment to purpose-driven growth, stating, “Now we have the opportunity to scale the enterprise with purpose by building on the strong foundation that’s already been established. Our goal is to be a trusted partner for biotech, pharma, and medtech innovators who require additional power to navigate clinical development and health economics.”
Recent Developments at Peritia
Mr. Griffith’s appointment coincides with Peritia’s recent rebranding and the consolidation of BioBridges, CHEORS, and Monitorforhire into a cohesive platform. This strategic move aims to enhance the company’s offerings in corporate and product strategy, operational execution, as well as value, evidence, and access.
With a proven track record in building high-performance cultures and scaling life sciences service organisations, Mr. Griffith is well-positioned to further accelerate Peritia’s mission of guiding life sciences organisations from concept to commercialisation.
Peritia is a global consulting firm specialising in biopharmaceutical and medtech sectors, with a focus on clinical development and value and evidence generation. The company connects industry-leading talent with organisations across the life sciences ecosystem to facilitate the efficient and effective delivery of innovations to patients. In the past five years, Peritia has completed over 1,100 engagements for 335 clients globally.
For more information about funding opportunities, please visit this link.